BCHILD - Bosutinib in Pediatric Patients [Denmark, France, Germany, Ireland, Israel, Italy, Netherlands, Spain, Switzerland, UK, USA]

Study title

Bosutinib in Pediatric CML Patients (ITCC-054/COG AAML1921)

Scientific title

A Phase I/II study of Bosutinib in pediatric patients with newly diagnosed chronic phase or resistant/intolerant Ph+ Chronic Myeloid Leukemia,
study ITCC-054/COG AAML1921 (ClinicalTrials.gov NCT04258943; EudraCT no. 2015-002916-34)

Indication and most important inclusion criteria

Pediatric CML patients aged 1 up to 18 years with newly diagnosed chronic phase CML, or patients who are resistant (suboptimal response or failure, as defined by 2013 European Leukemia Net guidelines) or intolerant (with or without suboptimal response or failure) to at least one prior tyrosine kinase inhibitor (TKI).

To be included, patients need to have adequate renal, liver and heart function as well as a Lansky performance status of at least 50% for patients up to 16 years of age, or a Karnofsky scale of at least 50% for patients over 16 years of age. Lansky performance status and Karnofsky scale are used to assess to what extent patients are able to carry on normal activities.

Short description of intervention

In this dose-finding study, the recommended dose of bosutinib will be determined based on the safety and tolerability profile of bosutinib.

Type of study

Pediatric trial

Current status


Study sponsor

Erasmus Medical Centre, Rotterdam, and Children's Oncology Group (for USA sites) with support from Pfizer

Scientific lead / contact

Prof. Dr. CM Zwaan
Erasmus Medical Centre
Rotterdam, Netherlands

Principal investigator

Prof. Dr. CM Zwaan
Erasmus Medical Centre
Rotterdam, Netherlands

For USA:
Dr. Hijiya
Columbia University Irving Medical Center
New York, N.Y.

Additional information

Study description in the EU Clinical Trials Register which is hosted by the European Medicines Agency (EMA)

Study description in the Nederlands Trials Register

Study centers / principal investigators


Dr. Karsten Nysom
2100 Copenhagen


Institut d'hématologie et d'oncologie pédiatrique- IHOP
Dr. Yves Bertrand
69008 Lyon

Hôpital Mère-Enfant, CHU de Nantes,
Dr. Fanny Rialland
44093 Nantes Cedex 01

Hôpital Armand Trousseau
Dr. Petit
75012 Paris

Hôpital Robert Debré
Dr. Brethon
75019 Paris


Universitätsklinikum Erlangen
Prof. Dr. Markus Metzler
91054 Erlangen

Universitätsklinikum Essen
Dr. Reinhardt
Hufelandstrasse 55
45147 Essen


Our Lady’s Children’s Hospital Crumlin
Dr. Owen Smith
Crumlin, Dublin 12


Tel Hashomer:
Sheba - Academic Medical Center Hospital
Dr. Bella Bielorai
Tel Hashomer, 52621


Clinica Pediatrica universita’ Milano Bicocca, Fondazione MBBM
Dr. Carmelo Rizzari
20900 Monza

Ospedale pediatrico bambino gesu’
Dr. Locatelli
Piazza S.Onofrio, 4, Rome

Regina Margherita Children’s Hospital
Dr. Bertorello
Piazza Polonia 94, 10126 Torino


Erasmus MC
Prof. Dr. CM Zwaan
3015GN Rotterdam

Princess Maxima center for pediatric oncology
Dr. Inge van der Sluis
3584 CS Utrecht


Hospital Universitari Vall d’Hebron
Dr. P. Velasco
08035 Barcelona

Hospital Niño Jesus
Dr. Francisco Bautista
28009 Madrid


Universitäts-Kinderspital Zürich
Dr. J.P. Bourquin
8032 Zurich

United Kingdom

Birmingham Children’s Hospital
Dr. Motwani
Steelhouse Lane, Birmingham, B4 6NH

The Royal Marsden NHS Foundation Trust Hospital
Dr. Donna Lancaster
Sutton, Surrey, SM2 5PT

United States


Arkansas Children's Hospital
Little Rock, Arkansas, 72202-3591
Principal Investigator: David Becton, MD


Kaiser Permanente Downey Medical Center
Downey, 90242
Principal Investigator: Robert Cooper, MD

Loma Linda University Medical Center
Loma Linda, California, 92354
Principal Investigator: Albert Kheradpour, MD

Kaiser Permanente-Oakland
Oakland, California, 94611
Principal investigator: Laura Campbell

Children's Hospital of Orange County
Orange, California, 92868
Principal investigator: Jamie Frediani


University of Florida Health Science Center - Gainesville
Gainesville, Florida, 32610
Principal Investigator: William Slayton

Nemours Children's Hospital
Orlando, Florida, 32827
Principal Investigator: Ramamoorthy Nagasubramanian, MD


Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, 96826
Principal Investigator: Wade T. Kyono


Riley Hospital for Children
Indianapolis, 46202
Principal Investigator: Sandeep Batra, MD

New Jersey

Hackensack University Medical Center
Hackensack, 07601
Principal Investigator: Burton Appel, MD

Morristown Medical Center
Morristown, 07960
Principal Investigator: John Gregory, MD


Children's Mercy Hospitals and Clinics
Kansas City, Missouri, 64108
Principal Investigator: Keith August, MD MSc


Children's Specialty Center of Nevada II
Las Vegas, Nevada, 89109
Principal Investigator: Alan Ikeda

New Jersey

Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital
New Brunswick, New Jersey, 08903
Principal Investigator: Richard A. Drachtman, MD

New York
The Steven and Alexandra Cohen Children's Medical Center of New York
New Hyde Park, 11040
Principal Investigator: Arlene Redner, MD

North Carolina
Carolinas Medical Center/Levine Cancer Institute
Charlotte, 28203
Principal Investigator: Joel Kaplan, DO MPH


Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229
Principal Investigator: Robin Norris, MD MPH


Lehigh Valley Hospital-Cedar Crest
Bethlehem, 18017
Principal Investigator: Jacob Troutman, DO

Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, 15224
Principal Investigator: Andrew Bukowinski, MD

East Tennessee Childrens Hospital
Knoxville, 37916
Principal Investigator: Susan Spiller, MD

Vanderbilt University/Ingram Cancer Center
Nashville, 37232
Principal Investigator: Scott Borinstein, MD PhD


Dell Children's Medical Center of Central Texas
Austin, Texas, 78723
Principal Investigator: Shannon Cohn, MD

UT Southwestern Medical Center Simmons Cancer Center
Dallas, Texas, 75235-9063
Principal investigator: Tamra Slone


Children's Hospital of Kings Daughters
Norfolk, Virginia, 23507
Principal investigator: Eric Lowe






EU e-Privacy Directive